Author

Sylvie Adam-Stitah

Observed name: Sylvie Adam Stitah

Institutions: Novartis (Switzerland), PRA Health Sciences

Observed institutions: Novartis (Switzerland), Centre National de la Recherche Scientifique, Inserm, Collège de France, Heidelberg University, University Hospital Heidelberg, Institut de génétique et de biologie moléculaire et cellulaire, PRA Health Sciences

OpenAlex ID: A5073746221

TFIIH Interacts with the Retinoic Acid Receptor γ and Phosphorylates Its AF-1-activating Domain through cdk7

2000 · Julie Bastien, Sylvie Adam-Stitah, et al. · Journal of Biological Chemistry · 118

Hyperphosphorylation of the Retinoid X Receptor α by Activated c-Jun NH2-terminal Kinases

1999 · Sylvie Adam-Stitah, Lucia Penna, et al. · Journal of Biological Chemistry · 89

Retinoids Inhibit the Actions of Angiotensin II on Vascular Smooth Muscle Cells

2001 · Volker Haxsen, Sylvie Adam-Stitah, et al. · Circulation Research · 67

Metabolism and Disposition of Siponimod, a Novel Selective S1P1/S1P5 Agonist, in Healthy Volunteers and In Vitro Identification of Human Cytochrome P450 Enzymes Involved in Its Oxidative Metabolism

2018 · Ulrike Glaenzel, Yi Jin, et al. · Drug Metabolism and Disposition · 57

Phosphorylation of the Retinoid X Receptor at the Omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity

2005 · Nathalie Bruck, Julie Bastien, et al. · Cellular Signalling · 55

The Phosphorylation Site Located in the A Region of Retinoic X Receptor α Is Required for the Antiproliferative Effect of Retinoic Acid (RA) and the Activation of RA Target Genes in F9 Cells

2002 · Julie Bastien, Sylvie Adam-Stitah, et al. · Journal of Biological Chemistry · 48

Phosphorylation des recepteurs des retinoides rar et rxr. Consequences sur la transcription, la differenciation et la proliferation

1999 · Sylvie Adam Stitah

Works count: 7

Citation count: 434

H-index: 6

I10-index: 6